Ruphesh Kotecha, MD,
Open to Accrual
Brain [BN]
Other
III
No
To determineif the time to local failure is improved with FSRS compared to SRS in patientswith intact (i.e., unresected) brain metastases
Patients must have pathologically proven diagnosis ofnon-small cell lung cancer, melanoma, breast cancer, renal cell carcinoma, orgastrointestinal cancer within 5 years prior to registration. Patients musthave at least 1 and up to 8 total intact brain metastases detected on acontrast-enhanced MRI performed ≤ 21 days prior to registration.
269
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.